Tejara Capital LTD Heron Therapeutics, Inc. Transaction History
Tejara Capital LTD
- $210 Billion
- Q3 2024
A detailed history of Tejara Capital LTD transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 5,305,816 shares of HRTX stock, worth $6.47 Million. This represents 5.03% of its overall portfolio holdings.
Number of Shares
5,305,816
Previous 4,187,860
26.7%
Holding current value
$6.47 Million
Previous $14.7 Billion
27.96%
% of portfolio
5.03%
Previous 5.33%
Shares
8 transactions
Others Institutions Holding HRTX
# of Institutions
180Shares Held
121MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$32.6 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$10.8 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$10.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$10.2 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$8.52 Million28.8% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $145M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...